ArticleBone marrow transplantation2007

Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer.

U De Giorgi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.